1.Targeting abnormal lipid metabolism of T cells for systemic lupus erythematosus treatment

Hu, JQ, Yan, YH, Xie     More...

Hu, JQ, Yan, YH, Xie, H, Feng, XB, Ge, WH, Zhou, H, Yu, LL, Sun, LY, Xie, Y     Less

BIOMEDICINE & PHARMACOTHERAPY[0753-3322], Published 2023, Volume 165,

收錄情况： WOS SCOPUS

WOS核心合集引用: 3  2023影響因子:  6.9  发表年影響因子:  6.9 

2.Hepatoprotective effect of Typhaneoside on non-alcoholic fatty liver disease via farnesoid X receptor in vivo and in vitro

Zheng, Y, Zhao, J, M     More...

Zheng, Y, Zhao, J, Miao, DY, Xu, TT, Wang, LN, Liu, CH, Gao, Y, Yu, LL, Shen, CP     Less

BIOMEDICINE & PHARMACOTHERAPY[0753-3322], Published 2023, Volume 164,

收錄情况： WOS SCOPUS

WOS核心合集引用: 2  2023影響因子:  6.9  发表年影響因子:  6.9